Nomura Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $441K | Sell |
15,984
-90,799
| -85% | -$2.51M | ﹤0.01% | 817 |
|
|
2025
Q1 | $3.03M | Buy |
106,783
+6,603
| +7% | +$187K | 0.01% | 671 |
|
|
2024
Q4 | $4.17M | Sell |
100,180
-14,155
| -12% | -$589K | 0.01% | 616 |
|
|
2024
Q3 | $7.64M | Buy |
114,335
+1,635
| +1% | +$109K | 0.02% | 475 |
|
|
2024
Q2 | $13.4M | Sell |
112,700
-7,779
| -6% | -$924K | 0.05% | 321 |
|
|
2024
Q1 | $12.8M | Buy |
120,479
+3,226
| +3% | +$344K | 0.05% | 328 |
|
|
2023
Q4 | $11.7M | Sell |
117,253
-2,769
| -2% | -$275K | 0.05% | 337 |
|
|
2023
Q3 | $12.4M | Buy |
120,022
+552
| +0.5% | +$57K | 0.06% | 303 |
|
|
2023
Q2 | $14.5M | Sell |
119,470
-4,567
| -4% | -$555K | 0.07% | 279 |
|
|
2023
Q1 | $19M | Sell |
124,037
-821
| -0.7% | -$126K | 0.1% | 236 |
|
|
2022
Q4 | $22.4M | Buy |
124,858
+1,522
| +1% | +$273K | 0.13% | 178 |
|
|
2022
Q3 | $14.6M | Sell |
123,336
-9,607
| -7% | -$1.14M | 0.09% | 244 |
|
|
2022
Q2 | $19M | Sell |
132,943
-490
| -0.4% | -$70K | 0.12% | 190 |
|
|
2022
Q1 | $23M | Sell |
133,433
-15,603
| -10% | -$2.69M | 0.13% | 169 |
|
|
2021
Q4 | $37.9M | Buy |
149,036
+72,641
| +95% | +$18.4M | 0.19% | 112 |
|
|
2021
Q3 | $29.4M | Sell |
76,395
-10,193
| -12% | -$3.92M | 0.17% | 133 |
|
|
2021
Q2 | $20.3M | Buy |
86,588
+11,038
| +15% | +$2.59M | 0.12% | 187 |
|
|
2021
Q1 | $9.89M | Buy |
75,550
+6,735
| +10% | +$882K | 0.06% | 301 |
|
|
2020
Q4 | $7.19M | Sell |
68,815
-8,798
| -11% | -$919K | 0.05% | 331 |
|
|
2020
Q3 | $5.49M | Sell |
77,613
-15,587
| -17% | -$1.1M | 0.04% | 352 |
|
|
2020
Q2 | $5.99M | Buy |
93,200
+64,200
| +221% | +$4.12M | 0.05% | 308 |
|
|
2020
Q1 | $869K | Buy |
+29,000
| New | +$869K | 0.01% | 724 |
|